We work in one market and
one audience.

India's healthcare professionals — and we do it with people, not proxies.

Why we built it this way

Most healthcare sample sold into India is brokered. It changes hands two or three times between the panel that recruited the respondent and the agency that fields the study, and by the time it reaches you nobody can say with confidence who answered.

We took the other route. Every member registered with us directly, confirmed their professional role against a national or state register, and is managed on infrastructure we control — so provenance is a question we can actually answer.

That matters more every year. As synthetic respondents and AI-generated open ends spread through online sample, the question stops being how large a panel is and becomes whether the people in it are real.

What that commits us to

We know this market because
we work inside it.

Three colleagues in discussion around a meeting table with laptops
  1. 01

    Provenance you can audit

    Because we own the recruitment channels, we can tell you which channel a respondent came from — and retire a channel when it underperforms.

  2. 02

    India as expertise, not arbitrage

    We are not the cheap option. We are the one that understands referral pathways, prescribing authority and payer mix here.

  3. 03

    Narrow on purpose

    Healthcare professionals only. No consumer panel with a medical filter applied over the top.

  4. 04

    One team, brief to delivery

    The people who manage the panel are the people who script, field and clean your study.

Real clinicians. Verified twice. Reachable on request.

Request feasibility → See who's on the panel